$66.82

-1.87%

BMY

Bristol-Myers Squibb Company

•Healthcare

Biopharmaceuticals

Oncology

High Dividend

Value Investing

Biopharmaceuticals

Oncology

High Dividend

Value Investing

Loading Chart...

FIT ANALYSIS

Required for personalization

FIT ANALYSIS

Checking Membership...

STOCK DNA

Valuation

6/10

Quality

7/10

Growth

6/10

Strength

4/10

Dividend

7/10

Similar Stocks

NVS Novartis AG

AZN AstraZeneca PLC

REGN Regeneron Pharmaceuticals, Inc.

MRK Merck & Company, Inc.

BIIB Biogen Inc.

Health Indicators

Price Trend

Upwards

Momentum

Stretched

Balance Sheet

High Leverage

Earnings

Growth

Dividend Yield

3.70%

Market Cap

$136.49B

TALK TO YOUR STOCK

EQUITAI ASSISTANT

Bristol-Myers Squibb is a global pharmaceutical company that discovers, develops, and delivers medicines for serious diseases. Its core products focus on treating cancer, cardiovascular conditions, and immunological disorders. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.

Talk to Your Stock•open live chat

Pro EquitAI Research

Retrieving premium status...